Olympus will support the COPD Foundation in its development of informative content that communicates to people with severe emphysema
Olympus has signed a partnership agreement with the COPD Foundation to support patient education about different treatment options for severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
“The COPD Foundation works tirelessly to speed innovations that make treatment more effective and affordable,” said Lynn Ray, Global General Manager and VP, Respiratory for Olympus. “For individuals struggling with breathlessness, education about treatment options like endobronchial valves couldn’t be more important.”
Treatment options to improve the lives of people living with COPD and other lung conditions include endobronchial valve procedures, during which endobronchial valves are placed into selected airways of emphysematous lungs to redirect air away from diseased parts of the lung. This treatment allows patients with severe emphysema to breathe more easily and experience improvement in their quality of life.
Olympus will support the COPD Foundation in its development of informative content that communicates to people with severe emphysema how endobronchial valves work and why they may be a treatment option for them.
“We are pleased to have the support of Olympus,” said Kristen Willard, VP, Public and Professional Education, COPD Foundation. “The COPD Foundation is dedicated to expanding services to people with COPD. The more effective education we can bring to individuals with severe emphysema, the better.”
